Informations générales (source: ClinicalTrials.gov)
Pilot Study: Describe the Effect of the Optimized Hemodialysis Technique (HDx) With Medium Cut-Off Membrane on Recovery Time and Quality of Life
Interventional
N/A
Ramsay Générale de Santé (Voir sur ClinicalTrials)
décembre 2022
octobre 2024
07 juin 2026
In this study, the effect of optimizing the dialytic technique using simple
questionnaires carried out in clinical routine will be described.
More specifically, the conventional dialysis technique will be combined with biofeedback
software called HemoControl™. The recovery time and quality of life of patients who will
use a polyethersulfone membrane (Revaclear®) and a Medium Cut-Off (MCO) membrane
(Theranova®) will be observed.
The main objective is to describe the evolution of recovery time after a dialysis session
in conventional hemodialysis (HD) on Revaclear® membrane and in so-called optimized
hemodialysis (HDx) on MCO membrane, Theranova®.
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| HOPITAL PRIVE CLAUDE GALIEN | Contact (sur clinicalTrials) | ||||
Critères
Tous
- Patient, male or female (using contraceptives, if of childbearing age), over 18
years of age
- Patient on conventional hemodialysis with synthetic membrane for at least 3 months
- Patient with a recovery time after the dialysis session ≥ 4 hours
- Informed patient who has signed a written consent to participate in the study
- Affiliated patient or beneficiary of a social security scheme
Exclusion Criteria:
- Patient whose seniority of dialysis is less than 3 months
- Pregnant woman
- Protected patient: adult under guardianship, curatorship or other legal protection,
deprived of liberty by judicial or administrative decision
- Patient with severe cognitive impairment
- Medically unstable or frail patient
- Patient who did not sign an informed consent form accepting this research (refusal
of consent or absence of signature).